These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21351153)

  • 1. Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections.
    Uchida H; Chow TW; Mamo DC; Kapur S; Mulsant BH; Houle S; Pollock BG; Graff-Guerrero A
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1300-8. PubMed ID: 21351153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
    Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
    Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater loss of 5-HT(2A) receptors in midlife than in late life.
    Sheline YI; Mintun MA; Moerlein SM; Snyder AZ
    Am J Psychiatry; 2002 Mar; 159(3):430-5. PubMed ID: 11870007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
    Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
    Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
    Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2A receptor density is decreased in the at-risk mental state.
    Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
    Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
    Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
    Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
    Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
    Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
    Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Serotonin Release Is Reduced in Patients With Depression: A [
    Erritzoe D; Godlewska BR; Rizzo G; Searle GE; Agnorelli C; Lewis Y; Ashok AH; Colasanti A; Boura I; Farrell C; Parfitt H; Howes O; Passchier J; Gunn RN; Politis M; Nutt DJ; Cowen PJ; Knudsen GM; Rabiner EA
    Biol Psychiatry; 2023 Jun; 93(12):1089-1098. PubMed ID: 36635177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep deprivation increases cerebral serotonin 2A receptor binding in humans.
    Elmenhorst D; Kroll T; Matusch A; Bauer A
    Sleep; 2012 Dec; 35(12):1615-23. PubMed ID: 23204604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.